Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome.
D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy*; D001714:Bipolar Disorder / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008094:Lithium / Q000009:adverse effects / Q000627:therapeutic use; D016651:Lithium Carbonate; D011433:Propranolol / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D016651:Lithium Carbonate; D008094:Lithium; D011433:Propranolol